Skinspan: A Tiered Roadmap for Evidence-Based Skin Longevity

As longevity medicine matures, the concept of 'healthspan' — years lived in good health — has gained traction over simple lifespan extension. This 2025 comprehensive review by Kream, Fabi, and Boen from Cosmetic Laser Dermatology in San Diego formalizes an analogous concept for the skin: 'skinspan,' defined as the period during which skin maintains a youthful, healthy appearance and function. To the authors' knowledge, this is the first peer-reviewed introduction of the term alongside clinical recommendations.

The paper begins with a detailed molecular framework. Skin aging progresses through damage accumulation (UV-induced genomic instability, telomere attrition, proteostasis decline, and AGE formation), followed by failure of compensatory mechanisms (mitochondrial exhaustion, reduced IGF-1 secretion from senescent fibroblasts), and culminating in a senescent tissue state characterized by the senescence-associated secretory phenotype (SASP). SASP-driven cytokines — IL-6, IL-1β, and TNF-α — propagate 'inflammaging' and spread senescence to neighboring cells, accelerating visible aging.

Against this molecular backdrop, the authors evaluate interventions across lifestyle, topical, systemic, and procedural categories. Photoprotection is established as the single most impactful first-line intervention, given that UVR accounts for 80–90% of facial aging. Broad-spectrum UVA/UVB sunscreens suppress oxidative and inflammatory gene expression in keratinocytes and fibroblasts. Topical retinoids — particularly tretinoin 0.1%, which demonstrated an 80% increase in collagen type I in a vehicle-controlled trial — and topical L-ascorbic acid (which scavenges ROS, inhibits tyrosinase, and synergizes with sunscreen to suppress MMP-1) constitute the remainder of first-line recommendations. Lifestyle modifications including avoidance of smoking, pollution minimization, Mediterranean-style diet rich in polyphenols, quality sleep, and regular exercise are reviewed for their mechanistic contributions to reducing SASP, oxidative stress, and collagen degradation.

Second-line interventions center on laser and energy-based devices, which stimulate collagen remodeling and address photodamage at a structural level. Third-line emerging therapies include sirtuin activators (such as resveratrol and NAD+ precursors like nicotinamide), melatonin (which downregulates MMP-1 and mTOR while activating sirtuins), oxytocin-related peptides, stem cell-based treatments, and GLP-1 receptor agonist considerations — notably flagging the paradox that GLP-1 medications promoting caloric restriction may accelerate facial aging through fat loss. The authors synthesize all tiers into a practical clinical algorithm designed for the cosmetic consultation.

The paper's primary caveat is the uneven quality of evidence across tiers: while photoprotection and retinoids are supported by robust RCTs, many emerging interventions rely on in vitro, animal, or small pilot data. The authors explicitly call for more randomized controlled trials. Nonetheless, the skinspan framework offers a unifying, proactive clinical philosophy — shifting the aesthetic consult from reactive correction toward longitudinal skin health preservation.